Kyoto researchers studied 216 adults aged 23 to 81 and found that lower levels of naïve CD8+ T cells before vaccination predicted weaker antibody responses to COVID-19 mRNA vaccines.
I’m open-sourcing a multi-agent Long COVID project from my Master’s Program at UT Austin to explore the disease’s mechanisms, suggest interventions, and test combination treatments.
🧬 MENSA tech uses new antibodies to detect ongoing COVID-19 & viral reactivations in #LongCOVID. With 60% accuracy for SCV2, EBV, CMV, HSV2, it offers diagnostics from a single blood sample.
Differentiates between infection and vaccination responses.